Bacoside A

CAS : 11028-00-5

Ref. TM-T3426

Informations sur le produit

• Nom: Bacoside A
• Synonymes: (5R,8R,9S,10S,13R,14R,17S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-10-(hydroxymethyl)-4,4,8,14-tetramethyl-1,2,3,5,6,7,9,11,12,13,15,17-dodecahydrocyclopenta[a]phenanthren-16-one, 3-[(O-α-<span class="text-smallcaps">L</smallcap>-Arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxydammar-24-en-16-one, Dammar-24-en-16-one, 3-[(O-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-, Dammar-24-en-16-one, 3-[(α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-O-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
• CAS: 11028-00-5

Description

Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro. It exerts cytoprotective efficacy by attenuation of ROS generated through oxidative stress by an increase in the concentration of antioxidant enzymes and sustain membrane integrity which leads to restoring the damage caused by tBHP. Bacoside A can able to inhibit the progression of Experimental Autoimmune Encephalomyelitis (EAE) may be by the inhibition of inflammatory cytokines and chemokine evolved during active EAE. Bacoside A also has vasorelaxation.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 768.98
• Formule: C₄₁H₆₈O₁₃
• Degré de pureté: 98%
• Couleur/Forme: Solid